Acyl-CoA dehydrogenase substrate promiscuity limits the potential for development of substrate reduction therapy in disorders of valine and isoleucine metabolism https://www.biorxiv.org/content/10.1101/2022.11.22.517273v1?med=mas
Acyl-CoA dehydrogenase substrate promiscuity limits the potential for development of substrate reduction therapy in disorders of valine and isoleucine metabolism https://www.biorxiv.org/content/10.1101/2022.11.22.517273v1?med=mas